Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177736 · ClinicalTrials.gov registry record
Pharmacodynamic Parameters of Two Different Doses of Cefepime
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 180
- Enrollment target
NCT00177736: Completed study, sponsored by University of Pittsburgh.
NCT00177736 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177736 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
Pharmacokinetics is the study of the disposition of drugs in the body, while pharmacodynamics considers the interaction of the drug at the site of infection over time. Mathematical models of antibiotic pharmacodynamics are sometimes used to predict if antibiotic doses are sufficient to treat infection with organisms of different minimal inhibitory concentrations of the antibiotic. Based on these models, there has been speculation that the antibiotic cefepime dosed at one gram every 12 hours, is insufficient to kill all organisms within the "susceptible" range. This study of patients treated with cefepime will involve the collection of blood to determine cefepime concentrations, and determine if those concentrations are effective in killing the bacteria at the site of infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-12 |
What the finished NCT00177736 record still lists
NCT00177736 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00177736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00177736 about?
NCT00177736 is a clinical study titled "Pharmacodynamic Parameters of Two Different Doses of Cefepime". Pharmacokinetics is the study of the disposition of drugs in the body, while pharmacodynamics considers the interaction of the drug at the site of infection over time. Mathematical models of antibiotic pharmacodynamics are sometimes used to predict if antibiotic doses are sufficient to treat infecti...
What is the current status of trial NCT00177736?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2005-09. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00177736?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia